Effects of Liposome-encapsulated Arginine on Calcified Vascular Arginine/NO Pathway in Rats

LI Xia,YAN Ning,CHEN Jinsong,TANG Chaoshu

DOI: https://doi.org/10.3969/j.issn.1671-0126.2006.02.001

2006-01-01

Abstract:Objective: To observe the alternations of calcified vascular arginine/NO pathway and the effects of liposome-encapsulated arginine on vascular calcification and arginine/NO pathway.Methods: The vascular calcification model was produced by vitamin D_3.Vascular calcium contents,plasma arginine and nitrite contents,vascular cGMP contents,vascular nitric oxide synthase(NOS) activity and vascular arginine levels were detected.Results: Compared with the control group,the vascular calcium contents of the rats in vascular calcification group increased 7.5 times((P)0.01),plasma NO production reduced,vascular cGMP levels decreased,vascular NOS activity increased((P)0.01).The arginine contents,however,obviously decreased(-19.1%,(P)0.01).Compared with the calcification group,the vascular calcium contents of the rats injected by liposome-encapsulated arginine decreased 51.2%((P)0.01),the productions of plasma NO increased,vascular cGMP contents increased 5.1%((P)0.05),and the vascular arginine contents increased 15.7%((P)0.05).Conclusions: Liposome-encapsulated arginine may attenuate the vascular calcification of the rats and improve the disturbance of calcified vascular L-arginine/NOS/NO/cGMP pathway.Thus,it appears some potential clinical value that liposome-encapsulated arginine to the vascular calcification of atherosclerosis and other cardiovascular diseases.